Sponsored by:

Nuclear Medicine: Page 127

PET/CT tumor volume best predicts breast cancer survival
By Wayne Forrest
Whole-body metabolic tumor volume, as determined by FDG-PET/CT before treatment, is a reliable prognosticator of overall survival in patients who have invasive ductal carcinoma of the breast and distant metastases at the time of their initial diagnosis, according to a study published online July 23 in the American Journal of Roentgenology.
July 29, 2015
Navidea wins NIH grant
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals has received a $321,000 grant from the U.S. National Institutes of Health's (NIH) National Heart, Lung, and Blood Institute.
July 27, 2015
Guerbet bids to buy Mallinckrodt's contrast business
By Brian Casey
French contrast agent developer Guerbet plans to acquire the contrast media and injector business of U.S. firm Mallinckrodt. The $270 million deal will double Guerbet's annual revenues, expand its product line, and instantly make the company a major player in the U.S. contrast market.
July 26, 2015
Perma-Fix subsidiary partners with Digirad for Tc-99m deal
By AuntMinnie.com staff writers
Perma-Fix Environmental Services announced that its Polish subsidiary, Perma-Fix Medical, has finalized its partnership with nuclear medicine firm Digirad regarding technetium-99m (Tc-99m).
July 26, 2015
Blue Earth secures $28M in venture capital
By AuntMinnie.com staff writers
Blue Earth Diagnostics has received $27.9 million (25.4 million euros) in capital from U.K. venture fund Syncona Partners.
July 22, 2015
Lilly touts latest study on florbetapir's efficacy
By AuntMinnie.com staff writers
At this week's Alzheimer's Association International Conference in Washington, DC, Eli Lilly is touting a new study that shows how PET amyloid imaging with its florbetapir radiopharmaceutical (Amyvid) can change the diagnosis and management of patients with Alzheimer's disease.
July 22, 2015
SPECT distinguishes TBI, PTSD in broad population
By Wayne Forrest
SPECT is once again showing its value by distinguishing the fine line between post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) in nonmilitary patients, which should lead to better treatment for the disorders.
July 19, 2015
2015 07 17 15 49 21 422 Raji Ptsd Tbi Plos One 200
Dilon touts MBI for invasive lobular carcinoma
By AuntMinnie.com staff writers
Molecular breast imaging (MBI) developer Dilon Diagnostics is highlighting a study that suggests MBI is a sensitive technique for diagnosing invasive lobular carcinoma, a breast cancer that tends to be difficult to detect.
July 16, 2015
Brain SPECT shows improvement after cocaine users abstain
By Wayne Forrest
Dysfunction in the prefrontal cortex region of the brain caused by excessive cocaine use may be reversed to some degree after more than one month of abstinence, researchers from Uruguay have found. Their findings are promising news for rehabilitation efforts, but the group cautioned that some brain dysfunction does appear to remain.
July 9, 2015
2015 07 09 16 42 54 230 Ferrando Cocaine Slide14 200
Blue Earth gets orphan drug status
By AuntMinnie.com staff writers
Blue Earth Diagnostics has received two orphan drug designations for its F-18 fluciclovine radiopharmaceutical for diagnosing glioma.
July 7, 2015
PET suggests link between anxious parents, children
By AuntMinnie.com staff writers
PET imaging of rhesus monkeys has shown how an overactive circuit in three regions of the brain may contribute to parent-to-child transmission of anxiety and depression. The findings were published online July 6 in the Proceedings of the National Academy of Sciences.
July 7, 2015
2015 07 09 10 09 18 710 Child Crying Anxiety 200
Isologic opens Toronto cyclotron facility
By AuntMinnie.com staff writers
Isologic Innovative Radiopharmaceuticals has opened a new cyclotron and radiopharmaceutical manufacturing facility at Toronto's Sunnybrook Health Sciences Centre.
July 7, 2015
Previous Page
Page 127 of 440
Next Page